Robert E. Hoffman's Insider Trades & SAST Disclosures
Robert E. Hoffman's most recent trade in Esperion Therapeutics Inc. was a trade of 40,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on April 1, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Robert E. Hoffman.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Esperion Therapeutics Inc. | Robert E. Hoffman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| TuHURA Biosciences Inc. | Robert E. Hoffman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 51,275 | 51,275 | - | - | Options (Right to Buy) | |
| FibroBiologics Inc | Robert E. Hoffman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Aug 2024 | 5,000 | 5,000 | - | - | Stock Option (Right to Buy) | |
| TuHURA Biosciences Inc. | Robert E. Hoffman | Director, President, CEO, and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 59,800 | 68,902 (0%) | 0% | 0 | Common Stock, par value $0.001 per share | |
| TuHURA Biosciences Inc. | Robert E. Hoffman | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2022 | 1,200,634 | 1,200,634 | - | - | Option (right to buy) | |
| TuHURA Biosciences Inc. | Robert E. Hoffman | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2022 | 400,145 | 455,145 (3%) | 3% | 0 | Common Stock | |
| TuHURA Biosciences Inc. | Robert E. Hoffman | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.47 per share. | 15 Feb 2022 | 55,000 | 55,000 (0%) | 0% | 0.5 | 25,795 | Common Stock |
| TuHURA Biosciences Inc. | Robert E. Hoffman | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2021 | 3,519,170 | 3,519,170 | - | - | Options (Right to Buy) | |
| TuHURA Biosciences Inc. | Robert E. Hoffman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Sep 2021 | 100,000 | 100,000 | - | - | Options (Right to Buy) | |
| Kura Oncology Inc | Robert E. Hoffman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2021 | 23,000 | 23,000 | - | - | Option to purchase common stock | |
| TuHURA Biosciences Inc. | Robert E. Hoffman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2020 | 120,000 | 120,000 | - | - | Options (Right to Buy) | |
| TuHURA Biosciences Inc. | Robert E. Hoffman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2020 | 39,567 | 75,000 | - | - | Options (Right to Buy) | |
| Kura Oncology Inc | Robert E. Hoffman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2020 | 23,000 | 23,000 | - | - | Option to purchase common stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges